Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P04626 (
erbB-2
)
5,251
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Phospholipase D (PLD) activity is elevated in response to most mitogenic signals. Two mammalian PLD genes (PLD1 and
PLD2
) have been cloned and their gene products have been characterized. PLD1 is a downstream target of the Ras/RalA GTPase cascade implicated in mitogenic and oncogenic signaling. Consistent with a role in mitogenic signaling, elevated expression of PLD1 transforms cells overexpressing the
epidermal growth factor (EGF) receptor
(EGFR). However,
PLD2
colocalizes with the EGFR in caveolin-enriched light membrane microdomains. We therefore investigated whether
PLD2
could also contribute to the transformation of cells overexpressing a tyrosine kinase. We report here that elevated expression of
PLD2
transforms rat fibroblasts overexpressing either the EGFR or c-Src. Since overexpression of a tyrosine kinase is a common genetic alteration in several human cancers, these data suggest that elevation of either PLD1 or
PLD2
may contribute to the progression to a malignant phenotype in cells with elevated tyrosine kinase activity.
...
PMID:Transformation of cells overexpressing a tyrosine kinase by phospholipase D1 and D2. 1174 Dec 92